RepliCel Life Sciences Inc.

    RepliCel Life Sciences Inc.

    TTSXV:RP
    - -
    CAD
    - -
    - -
    RepliCel Life Sciences Inc.
    TSXV:RP
    (TSX Venture Exchange)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2007
    2008
    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    TTM
    CAD
    - -
    - -
    - -
    - -
    - -
    - -
    0.91
    - -
    - -
    - -
    - -
    0.01
    0.01
    0.01
    0.01
    0.01
    0.01
    Revenue per Share
    -4.96
    -1.35
    0.63
    -1.18
    -1.06
    -0.79
    -0.01
    -1.02
    -0.89
    -0.54
    -0.32
    -0.13
    -0.12
    -0.06
    -0.13
    -0.02
    - -
    Basic EPS, GAAP
    -2.41
    -1.12
    -1.36
    -0.42
    -0.9
    -0.7
    0.11
    -0.88
    -0.77
    -0.45
    -0.29
    0.02
    -0.12
    -0.03
    -0.08
    -0.04
    -0.03
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    -75.41
    -74.16
    -73.52
    0.11
    -1.97
    -2.4
    -2.27
    -3.04
    -3.61
    -0.36
    -0.25
    -0.3
    -0.38
    -0.36
    -0.37
    -0.3
    -0.21
    Book Value per Share
    -0.82
    -2.15
    -1.52
    0.32
    0.11
    - -
    0.33
    0.35
    -0.11
    0.15
    -0.02
    -0.09
    -0.18
    -0.19
    -0.21
    -0.16
    -0.11
    Tangible Book Value per Share
    - -
    - -
    - -
    2
    3
    4
    5
    5
    6
    8
    19
    22
    24
    27
    32
    38
    58
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    4
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    9.3
    - -
    - -
    - -
    - -
    -1,608.85
    -827.41
    -375.5
    -649.78
    -393.71
    -387.01
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    -1
    - -
    - -
    -3
    -4
    -3
    - -
    -5
    -5
    -4
    -6
    -3
    -3
    -2
    -4
    -1
    - -
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    107.45
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    -0.69
    - -
    - -
    - -
    - -
    -1,660.41
    -849.27
    -446.74
    -1,151.52
    -210.11
    -19.59
    Profit Margin (%)
    - -
    - -
    - -
    1
    - -
    - -
    2
    2
    -1
    1
    - -
    1
    -1
    -2
    -1
    -1
    -1
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    LT Debt
    - -
    - -
    - -
    1
    - -
    - -
    1
    2
    -1
    1
    - -
    -2
    -4
    -5
    -7
    -6
    -7
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    -3.82
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    0.28
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    6.34
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Mar'23
    Jun'23
    Sep'23
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    65
    65
    65
    Market Capitalization
    6
    9
    7

    Working Capital

    CAD

    •

    in mil. unless spec.
    Mar'23
    Jun'23
    Sep'23
    Total Current Assets
    1
    - -
    - -
    Cash, Cash Equivalents & STI
    1
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    2
    1
    2
    Payables & Accruals
    1
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    699.47%
    132.56%
    -13.55%
    Free Cash Flow
    -172.93%
    -125.7%
    -43.93%
    Net Income, GAAP
    1,800.02%
    -3.44%
    -81.75%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    -0.04
    -0.03
    -0.03
    - -
    -0.13
    2022
    -0.02
    -0.03
    -0.03
    - -
    -0.02
    2023
    -0.02
    -0.01
    -0.01
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business